HomeNewsBusinessEarningsGlenmark Pharma Mar qtr PAT seen down at Rs 98.8 cr: MOST

Glenmark Pharma Mar qtr PAT seen down at Rs 98.8 cr: MOST

Motilal Oswal has come out with its earning estimates on Pharmaceuticals sector for the quarter ended March 2011. According to the research firm, Glenmark Pharma March quarter sales are expected to go up by 7% at Rs 759 crore, year-on-year, (YoY) basis.

Motilal Oswal has come out with its earning estimates on Pharmaceuticals sector for the quarter ended March 2011. According to the research firm, Glenmark Pharma March quarter sales are expected to go up by 7% at Rs 759 crore, year-on-year, (YoY) basis.

The company's net profit is expected to go down by 3.7% at Rs 98.8 crore on YoY basis.

first published: Apr 15, 2011 12:01 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Glenmark Pharma Mar qtr PAT seen down at Rs 98.8 cr: MOST

Motilal Oswal has come out with its earning estimates on Pharmaceuticals sector for the quarter ended March 2011. According to the research firm, Glenmark Pharma March quarter sales are expected to go up by 7% at Rs 759 crore, year-on-year, (YoY) basis.

News

Features

Tools

Specials

Network 18 Sites

Personal Finance

Quick Links